We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $235B
1-Year Est. Return 32.99%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+0.54%
1 Year Est. Return
+32.99%
3 Year Est. Return
+97.19%
5 Year Est. Return
+117.91%
10 Year Est. Return
+456.21%
AUM
$126B
AUM Growth
+$2.34B
Cap. Flow
+$2.62B
Cap. Flow %
2.07%
Top 10 Hldgs %
21.09%
Holding
8,008
New
182
Increased
3,096
Reduced
3,760
Closed
268

Sector Composition

Rank Sector Weight
1 Technology 6.16%
2 Financials 5.29%
3 Healthcare 5.26%
4 Consumer Discretionary 4.52%
5 Communication Services 3.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INO icon
7226
PUT
Inovio Pharmaceuticals
INO
$79.4M
$4K ﹤0.01%
158
-142
-47% -$4.32K
JILL icon
7227
J. Jill
JILL
$261M
$4K ﹤0.01%
455
-406
-47% -$4.13K
MEC icon
7228
Mayville Engineering Co
MEC
$751M
$4K ﹤0.01%
312
-1,454
-82% -$19.4K
MNSB icon
7229
MainStreet Bancshares
MNSB
$166M
$4K ﹤0.01%
178
-1,635
-90% -$35.6K
MRSN
7230
DELISTED
Mersana Therapeutics
MRSN
$4K ﹤0.01%
93
-274
-75% -$19.9K
NMFC icon
7231
New Mountain Finance
NMFC
$649M
$4K ﹤0.01%
290
NXTC icon
7232
NextCure
NXTC
$20.8M
$4K ﹤0.01%
12
-55
-82% -$17.9K
ORGO icon
7233
Organogenesis Holdings
ORGO
$328M
$4K ﹤0.01%
522
-2,430
-82% -$13.5K
PRPL icon
7234
Purple Innovation
PRPL
$35.8M
$4K ﹤0.01%
23
-15
-39% -$2.75K
PRTA icon
7235
CALL
Prothena Corp
PRTA
$455M
$4K ﹤0.01%
500
-100
-17% -$888
PXF icon
7236
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.84B
$4K ﹤0.01%
90
-168
-65% -$6.63K
PXLW icon
7237
Pixelworks
PXLW
$37.9M
$4K ﹤0.01%
83
QNCX icon
7238
Quince Therapeutics
QNCX
$17.5M
$4K ﹤0.01%
1
-3
-75% -$18.5K
RIGL icon
7239
CALL
Rigel Pharmaceuticals
RIGL
$692M
$4K ﹤0.01%
220
-160
-42% -$3.31K
TPST icon
7240
Tempest Therapeutics
TPST
$14.9M
$4K ﹤0.01%
2
-11
-85% -$17.8K
USRT icon
7241
iShares Core US REIT ETF
USRT
$4.73B
$4K ﹤0.01%
65
WTMF icon
7242
WisdomTree Managed Futures Strategy Fund
WTMF
$244M
$4K ﹤0.01%
103
XTL icon
7243
State Street SPDR S&P Telecom ETF
XTL
$568M
$4K ﹤0.01%
55
YRD
7244
Yiren Digital
YRD
$103M
$4K ﹤0.01%
+609
New +$6.27K
NESR
7245
National Energy Services Reunited Corp
NESR
$2.71B
$4K ﹤0.01%
596
-5,463
-90% -$42.5K
VIVS
7246
VivoSim Labs
VIVS
$1.36M
$4K ﹤0.01%
62
-21
-25% -$1.77K
MORF
7247
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$4K ﹤0.01%
+220
New +$4.61K
AIF
7248
DELISTED
Apollo Tactical Income Fund Inc.
AIF
$4K ﹤0.01%
253
-59
-19% -$878
DLA
7249
DELISTED
Delta Apparel Inc.
DLA
$4K ﹤0.01%
155
-1,598
-91% -$35.4K
CSML
7250
DELISTED
IndexIQ ETF Trust IQ U.S. Small Cap ETF
CSML
$4K ﹤0.01%
170

Similar funds

Citigroup's Q3 2019 Portfolio in Review

As of Q3 2019, Citigroup held 8,008 positions worth $126B, up 1.9% from $124B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Citigroup's Q3 2019 filing shows 182 new, 3,096 increased, 3,760 reduced and 268 closed positions. Its largest new stake was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M. The largest sale was iShares Russell 1000 Value ETF, an estimated $2.49B.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.8% a quarter earlier, followed by Financials and Healthcare.

  • Citigroup's largest Q3 2019 buy was Global X Genomics & Biotechnology ETF: 187,500 shares worth $9.38M.
  • Citigroup added most to State Street SPDR S&P 500 ETF Trust in Q3 2019, an estimated $1.26B increase.
  • Citigroup's biggest Q3 2019 reduction was iShares Russell 1000 Value ETF, cutting an estimated $2.49B.
  • Citigroup fully exited Red Hat Inc in Q3 2019, selling an estimated $311M.
  • Citigroup's ten largest holdings make up 21% of its $126B portfolio in Q3 2019.
  • Citigroup opened 182 new positions and closed 268 in Q3 2019.
  • Citigroup's portfolio value rose 1.9% quarter-over-quarter to $126B.

Based on Citigroup's 13F filing for Q3 2019, filed 8 Nov 2019.